Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Project Description:
Datamonitors' HemaQuest Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by HemaQuest Pharmaceuticals, Inc. since January 2007.
Scope:
– Provides intelligence on HemaQuest Pharmaceuticals, Inc.'s M&A, strategic partnerships and alliances, capital raising and private equity transactions. – Detailed reports of various financial transactions undertaken by HemaQuest Pharmaceuticals, Inc. and its subsidiaries since 2007. – Information about key financial and legal advisors for HemaQuest Pharmaceuticals, Inc.'s financial deals transactions. – Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
Highlights:
This report includes HemaQuest Pharmaceuticals, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by HemaQuest Pharmaceuticals, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Reasons to Purchase:
– Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances. – Form an independent opinion about HemaQuest Pharmaceuticals, Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007. – Track your competitors’ business structure and growth strategies.
Our reports have been used by over 10K customers, including:
532 pages •
By Global Industry Analysts
• Jul 2022
Abstract: What`s New for 2022? - Global competitiveness and key competitor percentage market shares - Market presence across multiple geographies - Strong/Active/Niche/Trivial - Online interactive peer-to-peer collaborative bespoke updates - Access to our digital archives and MarketGlass...
Bacterial Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Bacterial Conjunctivitis – Drugs In Development, 2022, provides an overview of the Bacterial Conjunctivitis...
120 pages •
By Infiniti Research Limited
• Jul 2022
Global Fertility Testing Devices Market 2022-2026 The analyst has been monitoring the fertility testing devices market and it is poised to grow by $ 153.91 mn during 2022-2026, accelerating at a CAGR of 5.73% during the forecast period. Our report on the fertility testing devices market provides a holistic analysis, market...
The global manufacturing operations management software market reached a value of US$ 9.5 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 17.5 Billion by 2027, exhibiting a CAGR of 11% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well...
Forecasts by Product Type (Monoclonal Antibodies, Vaccines, Protein Therapeutics Fusion Proteins and Regenerative Medicine), by Application (Oncology, Autoimmune Disorder, Infectious Diseases, Cardiovascular Disorders, Hematological Disorders, Others), by Manufacturing (Outsourced, In-house) AND Regional and Leading National Market...
576 pages •
By Global Industry Analysts
• Jul 2022
Abstract: What`s New for 2022? - Global competitiveness and key competitor percentage market shares - Market presence across multiple geographies - Strong/Active/Niche/Trivial - Online interactive peer-to-peer collaborative bespoke updates - Access to our digital archives and MarketGlass...
The Global Gas Chromatography Market size is expected to reach $3.7 billion by 2028, rising at a market growth of 5.4% CAGR during the forecast period. The method of separating specific compounds from compositions of volatile organic molecules is known as gas chromatography. Starting with a low oven temperature and progressively raising...
Neutropenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Neutropenia – Drugs In Development, 2022, provides an overview of the Neutropenia (Hematological Disorders) pipeline landscape. Neutropenia...
175 pages •
By The Business Research Company
• Jun 2022
Major players in the pharmacovigilance market are Accenture, Cognizant, Labcorp Drug Development, IQVIA, IQVIA, Parexel International Corporation, BioClinica Inc., Clinquest Inc., ITClinical, TAKE Solutions Limited, United BioSource LLC, Wipro Limited, Bristol-Myers Squibb Company, Linical Americas, iMEDGlobal, Boehringer Ingelheim International...
5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’5-Hydroxytryptamine Receptor 7 - Drugs In Development,...
Pharmaceutical
World
Depression Prevalence
Diagnostic Imaging Density
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.